What is the Org number of Oblique Therapeutics AB (publ)?

Oblique Therapeutics AB (publ) is registered with Bolagsverket / SCB under Org 5590174487.

What is the revenue of Oblique Therapeutics AB (publ)?

Oblique Therapeutics AB (publ) reported revenue of SEK 491K in 2024.

Karl Christer Emanuel Nordstedt is Chief Executive Officer of Oblique Therapeutics AB (publ), in role since 2022.

Daniel Johnsson chairs the board of Oblique Therapeutics AB (publ), in role since 2022.

Oblique Therapeutics AB (publ)'s registered address is Askim.

ABActive

Actively employed in the business

Name	Role	Member since
Current (2)
KC Karl Christer Emanuel Nordstedt Chief Executive Officer	Chief Executive Officer	2022
GR Gustav Rikard Sahle Chief Auditor	Chief Auditor	2025
Former (4)
ST Sven Tiberiu Cristea Audit	Audit	2020 – 2022
JO Jan Owe Owesson Orwar Chief Executive Officer	Chief Executive Officer	2020 – 2022
JD Johan Daniel Haglund Chief Auditor	Chief Auditor	2020 – 2024
UG Ulf Greger Johansson Längvik Chief Auditor	Chief Auditor	2024 – 2025

Non-executive oversight

Name	Role	Member since
Current (3)
JG Jonas Göran Ekblom	Board of Directors	2023
SB Søren Bregenholt Frederiksen	Board of Directors	2023
HA Hans-Peter Albert Ostler	Chairman	2020
Former (10)
LA Lars Anders Molinder	Board of Directors	2020 – 2023
EP Eva Pernilla Lovisa Stafshede	Board of Directors	2022 – 2023
LC Linnéa Carolina Trkulja	Board of Directors	2022 – 2022
MC M C Dicander Alexandersson	Board of Directors	2022 – 2025
CI Camilla Ingegerd Elisabeth Svensson	Board of Directors	2020 – 2025
BS Bengt Stefan Ståhl	Board of Directors	2020 – 2023
DJ Daniel Johnsson	Chairman	2022 – 2023
CT Claes Tomas Post	Deputy Board Member	2020 – 2020
AM Alexander Moscho	Board of Directors	2020 – 2021
LE Lennart Erik Jonas Sjögren	Board of Directors	2020 – 2020

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.